These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17292057)

  • 1. The pathway to commercialization for nanomedicine.
    Flynn T; Wei C
    Nanomedicine; 2005 Mar; 1(1):47-51. PubMed ID: 17292057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Will the nanomedicine "patent land grab" thwart commercialization?
    Bawa R
    Nanomedicine; 2005 Dec; 1(4):346-50. PubMed ID: 17292108
    [No Abstract]   [Full Text] [Related]  

  • 3. Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties.
    Nijhara R; Balakrishnan K
    Nanomedicine; 2006 Jun; 2(2):127-36. PubMed ID: 17292125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commercializing nanotechnology.
    Mazzola L
    Nat Biotechnol; 2003 Oct; 21(10):1137-43. PubMed ID: 14520392
    [No Abstract]   [Full Text] [Related]  

  • 5. Nanomedicine: real commercial potential or just hype?
    Webster TJ
    Int J Nanomedicine; 2006; 1(4):373-4. PubMed ID: 17722271
    [No Abstract]   [Full Text] [Related]  

  • 6. A look behind the rapid growth in healthcare IS.
    Dorenfest SI
    Healthc Inform; 1997 Jun; 14(6):SS29-30. PubMed ID: 10168120
    [No Abstract]   [Full Text] [Related]  

  • 7. The economics of personalized medicine: commercialization as a driver of return on investment.
    Keeling P; Roth M; Zietlow T
    N Biotechnol; 2012 Sep; 29(6):720-31. PubMed ID: 22713855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protecting new ideas and inventions in nanomedicine with patents.
    Bawa R; Bawa SR; Maebius SB; Flynn T; Wei C
    Nanomedicine; 2005 Jun; 1(2):150-8. PubMed ID: 17292072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring emerging nanobiotechnology drugs and medical devices.
    Paradise J; Diliberto GM; Tisdale AW; Kokkoli E
    Food Drug Law J; 2008; 63(2):407-20. PubMed ID: 18561467
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent advances in basic and clinical nanomedicine.
    Morrow KJ; Bawa R; Wei C
    Med Clin North Am; 2007 Sep; 91(5):805-43. PubMed ID: 17826104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invention and commercialization in optical bioimaging.
    Farkas DL
    Nat Biotechnol; 2003 Nov; 21(11):1269-71. PubMed ID: 14595349
    [No Abstract]   [Full Text] [Related]  

  • 12. The process of product selection in the medical instrument market.
    Hochberg HM
    Med Instrum; 1979; 13(6):344-6. PubMed ID: 522718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investing in nanotechnology.
    Paull R; Wolfe J; Hébert P; Sinkula M
    Nat Biotechnol; 2003 Oct; 21(10):1144-7. PubMed ID: 14520393
    [No Abstract]   [Full Text] [Related]  

  • 14. UK technology-boost plan disappoints.
    Bhattacharya A
    Nature; 2012 Sep; 489(7416):347. PubMed ID: 22996525
    [No Abstract]   [Full Text] [Related]  

  • 15. From innovation to successful commercialization: assessing value and investment--does the equation make sense?
    Toneguzzo F
    Surgery; 2008 Feb; 143(2):165-8. PubMed ID: 18242328
    [No Abstract]   [Full Text] [Related]  

  • 16. Beyond biotechnology: FDA regulation of nanomedicine.
    Miller J
    Columbia Sci Technol Law Rev; 2003; 4():E5. PubMed ID: 15977335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to commercialize nanotechnology.
    Helmus MN
    Nat Nanotechnol; 2006 Dec; 1(3):157-8. PubMed ID: 18654171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bringing smart pills to market: FDA regulation of ingestible drug/device combination products.
    Avery M; Liu D
    Food Drug Law J; 2011; 66(3):329-52, i. PubMed ID: 24505852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for developing and commercializing nanobio drugs, diagnostics and devices.
    Bunger M
    Nanomedicine (Lond); 2007 Apr; 2(2):137-41. PubMed ID: 17716115
    [No Abstract]   [Full Text] [Related]  

  • 20. Rainbow biotech--South Africa's emerging sector.
    Louët S
    Nat Biotechnol; 2006 Nov; 24(11):1313-6. PubMed ID: 17093464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.